| |
|
|
|
BioCryst Pharmaceuticals Inc.  
|
|
7.28 -0.03 (-0%) |
09-21 16:00 |
|
Open: |
7.28 |
Pre close: |
7.31 |
Target:
|
9.50
|
|
High: |
7.55 |
Low: |
7.185 |
Resistance:
|
8.13
9.50
|
|
Volume: |
519,778 |
Market Cap: |
796M |
Support:
|
6.81
6.00
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.21
 |
MACD |
MACD(12,26):
|
0.11  |
|
MA(20): |
7.30 |
Signal(12,26,9): |
0.16 |
|
MA(100): |
6.30 |
Stochastic Oscillator |
%K(14,3):
|
61.35 |
|
MA(250): |
5.51 |
%D(3): |
58.27 |
|
Average Volume(K) |
3-Month: |
71416
|
52-Week |
High:
|
8.13 |
|
10-Days: |
45029 |
Low: |
4.12 |
|
RSI |
RSI(14):
|
54.36 |
Change(%): |
38.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.830 |
Return on Equity (ttm) |
-222.9 |
Shares Out. (M) |
109.38 |
|
EPS Est. Current Year |
-0.750 |
Return on Assets (ttm) |
-62.4 |
Shares Float (M) |
105.29 |
|
EPS Est. Next Year |
-0.780 |
PEG Ratio |
-0.45 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
303.2 |
% Held by Institutions |
94.60 |
|
Forward EPS |
-0.900 |
Gross Profit (p.s.) |
0.069 |
Shares Short (K) |
9532 |
|
Book Value (p.s.) |
16.890 |
EBITDA (p.s.) |
-0.117 |
P/E |
-8.77 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.43 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-56.50 |
P/S |
2568665856.00 |
|
Operating Margin |
-224.16 |
Levered Free Cash Flow
(M) |
-21.52 |
P/CF |
-14.09 |
|
|
|
|
|
|
